|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.90 USD | -1.79% |
|
+1.05% | +10.93% |
| 06-11 | Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction | RE |
| 06-10 | TD Cowen Adjusts Price Target on DexCom to $95 From $75, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 29.04B | |||||
| 156B | |||||
| 103B | |||||
| 54.77B | |||||
| 53.52B | |||||
| 40.6B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
